Rapid IgG test 07RDCOV19
COVID-19IgMSARS-COV-2

rapid IgG test
rapid IgG test
rapid IgG test
Add to favorites
Compare this product
 

Characteristics

Applications
COVID-19
Tested parameter
IgG, IgM
Micro-organism
SARS-COV-2
Sample type
serum, plasma, whole blood
Analysis mode
immunochromatographic
Result display time

15 min

Specificity

95 %

Sensitivity

99 %

Description

MP Biomedicals now offers a rapid diagnostic test detecting IgG and IgM antibodies of COVID-19. MP Rapid 2019-nCoVIgG/IgM Combo Test Card is an immunochromatography-based one-step in vitro test. It is designed for the rapid qualitative determination of IgG and IgM antibodies to 2019 novel coronavirus (2019-nCoV, SARS-CoV-2) in human serum, plasma, or whole blood. MP Rapid 2019-nCoV IgG/IgM Combo Test Card is a supplementary detection for COVID-19 infected suspected individuals besides nucleic acid testing, which could greatly raise the accuracy of the detection for COVID-19. RAPID AND CONVENIENT: Results in 10 minutes. Requires no instruments. DETECTION OF DIFFERENT CLINICAL STAGES: Infection time can be roughly judges by detecting IgG or IgM. OPTIMIZED DETECTION: Can detect specific antibodies to both N and S virus proteins for improved serological detection rates. SPECIMENS: Easy sampling, only 2 μL of serum, plasma, or whole blood is needed. STORAGE: Room temperature, 18-month shelf life. Usage Statement This product is CE-IVD marked for professional use and complies with the European In-Vitro Diagnostic Devices Directive (98/79/EC). Not for sale in the USA.

Catalogs

No catalogs are available for this product.

See all of MP Biomedicals‘s catalogs

Other MP Biomedicals products

Infectious Disease

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.